See the source article by following the link below:
Cannabidiol significantly reduces seizure frequency and duration in patients with seizures associated with Lennox-Gastaut syndrome: a randomised, double-blind, placebo-controlled phase 3 trial
Cannabidiol significantly reduces seizure frequency and duration in patients with seizures associated with Lennox-Gastaut syndrome: a randomised, double-blind, placebo-controlled phase 3 trial
No comments:
Post a Comment